Paregoric: Difference between revisions

Jump to navigation Jump to search
Newer edit →
VisualWikitext
WikiBot (talk | contribs)
Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators
57,550 edits
m Protected "Paregoric": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))
 
Aparna Vuppala (talk | contribs)
nocaptcha, Administrators
6,313 edits
No edit summary
Line 1: Line 1:
'''Paregoric''', or [[camphor|camphorated]] [[tincture]] of [[opium]], is a [[medication]] known for its [[antidiarrheal]], [[antitussive]], and [[analgesic]] properties. It was a household remedy in the 18th and 19th centuries, when it was widely used to calm fretful children. But in the 20th century its use declined as governments regulated it. (In the United States, paregoric can still be found in the [[United States Pharmacopeia|pharmacopeia]], but it is a [[Schedule III]] drug under the [[Controlled Substances Act]].)
{{DrugProjectFormSinglePage
|authorTag=


The principal active ingredient is [[morphine]] (0.4 mg/mL). Other ingredients are [[benzoic acid]], [[camphor]] and [[anise oil]]. The main effect of this preparation is to increase the muscular tone of the intestine, and also to inhibit normal [[peristalsis]].  Its main medicinal use is to control [[fulminant]] [[diarrhea]].  It is also an [[antitussive]] (cough suppressant). Problems with its use include [[opiate dependency]] and analgesia which can mask symptoms of diseases that need treatment.


Paregoric is sometimes confused with [[laudanum]], because their chemical names are similar: camphorated tincture of opium (paregoric) vs. tincture of opium (laudanum).  However, laudanum contains 10 milligrams of morphine per milliliter, 25 times more than paregoric. Confusion between the two drugs has led to overdose and deaths in several patients.  Thus the term "paregoric" should always be used instead of "camphorated opium tincture," since the latter may be confused with laudanum.
<!--Overview-->


Paregoric is mentioned in the Nelson Algren short story "The Captain Has Bad Dreams".
|genericName=


Paregoric is featured in [[Richard Fariña]]'s novel ''[[Been Down So Long It Looks Like Up to Me]]''.


Paregoric and laudanum are mentioned in William Golding's novel ''Rites of Passage''.


Paregoric is also mentioned in [[William S. Burroughs]]'s [[epistolary]] novel ''[[The Yage Letters]]'' and his first novel ''[[Junky]]'', as well as ''[[Queer]]''.
|aOrAn=


Paregoric is mentioned in John Steinbeck's novel, "East of Eden."
a


It is also mentioned in James T. Farrell's Novel, "Studs Lonigan", "Go Ask Alice" by Anonymous and "The Adventure of The Three Gables" by Sir Arthur Conan Doyle.
|drugClass=


It is also used in the TV series "Little House on The Prairie" during the episode "A Matter of Faith" where the mother has a badly infected cut.
And also in the episode, "To live with fear" where the daughter, Mary is injured and has to have an operation.


It is also mentioned in the novel "Harmful Intent" (1990) by Robin Cook.
[[fr:Élixir parégorique]]


[[Category:Antidiarrhoeals]]
|indication=
[[Category:Opioids]]
 
[[Category:Drugs]]
 
{{WikiDoc Sources}}
 
|hasBlackBoxWarning=
 
Yes
 
|adverseReactions=
 
 
 
<!--Black Box Warning-->
 
|blackBoxWarningTitle=
Title
 
|blackBoxWarningBody=
<i><span style="color:#FF0000;">ConditionName: </span></i>
 
* Content
 
<!--Adult Indications and Dosage-->
 
<!--FDA-Labeled Indications and Dosage (Adult)-->
 
|fdaLIADAdult=
 
=====Diarrhea=====
*Paregoric is useful for the treatment of diarrhea.
=====Usual Adult Dosage=====
*5 to 10 mL (1 to 2 teaspoonfuls) 1 to 4 times a day or as directed by a physician.
 
<!--Off-Label Use and Dosage (Adult)-->
 
<!--Guideline-Supported Use (Adult)-->
 
|offLabelAdultGuideSupport=
 
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
<!--Non–Guideline-Supported Use (Adult)-->
 
|offLabelAdultNoGuideSupport=
 
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
<!--Pediatric Indications and Dosage-->
 
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
 
|fdaLIADPed=
Usual Pediatric Dosage
 
0.25 to 0.5 mL/kg of body weight 1 to 4 times a day or as directed by a physician.
 
<!--Off-Label Use and Dosage (Pediatric)-->
 
<!--Guideline-Supported Use (Pediatric)-->
 
|offLabelPedGuideSupport=
 
 
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Non–Guideline-Supported Use (Pediatric)-->
 
|offLabelPedNoGuideSupport=
 
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Contraindications-->
 
|contraindications=
 
* Condition1
 
<!--Warnings-->
 
|warnings=
 
* Description
 
====Precautions====
 
* Description
 
<!--Adverse Reactions-->
 
<!--Clinical Trials Experience-->
 
|clinicalTrials=
 
There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
 
 
 
<!--Postmarketing Experience-->
 
|postmarketing=
 
There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
 
 
<!--Drug Interactions-->
 
|drugInteractions=
 
* Drug
:* Description
 
<!--Use in Specific Populations-->
 
|useInPregnancyFDA=
* '''Pregnancy Category'''
 
|useInPregnancyAUS=
* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
 
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
 
|useInLaborDelivery=
There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
 
|useInNursing=
There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
 
|useInPed=
There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
 
|useInGeri=
There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
 
|useInGender=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
 
|useInRace=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
 
|useInRenalImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
 
|useInHepaticImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
 
|useInReproPotential=
There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
 
|useInImmunocomp=
There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
 
<!--Administration and Monitoring-->
 
|administration=
 
* Oral
 
* Intravenous
 
|monitoring=
 
There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
 
* Description
 
<!--IV Compatibility-->
 
|IVCompat=
 
There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
 
<!--Overdosage-->
 
|overdose=
 
 
 
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
 
<!--Pharmacology-->
 
<!--Drug box 2-->
 
|drugBox=
 
 
 
<!--Mechanism of Action-->
 
|mechAction=
 
*
 
<!--Structure-->
 
|structure=
 
*
 
: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
 
<!--Pharmacodynamics-->
 
|PD=
 
There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
 
<!--Pharmacokinetics-->
 
|PK=
 
There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
 
<!--Nonclinical Toxicology-->
 
|nonClinToxic=
 
There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
 
<!--Clinical Studies-->
 
|clinicalStudies=
 
There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
 
<!--How Supplied-->
 
|howSupplied=
 
*
 
<!--Patient Counseling Information-->
 
|fdaPatientInfo=
 
There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
 
<!--Precautions with Alcohol-->
 
|alcohol=
 
* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
 
<!--Brand Names-->
 
|brandNames=
 
* ®<ref>{{Cite web | title =  | url =  }}</ref>
 
<!--Look-Alike Drug Names-->
 
|lookAlike=
 
* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
 
<!--Drug Shortage Status-->
 
|drugShortage=
}}
 
<!--Pill Image-->
 
 
<!--Label Display Image-->
 
{{LabelImage
|fileName={{PAGENAME}}11.png|This image is provided by the National Library of Medicine.
}}
 
{{LabelImage
|fileName={{PAGENAME}}11.png|This image is provided by the National Library of Medicine.
}}
 
<!--Category-->
 
[[Category:Drug]]

Revision as of 18:45, 24 April 2015

Paregoric
Black Box Warning
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

Title
See full prescribing information for complete Boxed Warning.
ConditionName:
  • Content

Overview

Paregoric is a that is FDA approved for the {{{indicationType}}} of . There is a Black Box Warning for this drug as shown here. Common adverse reactions include .

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Diarrhea
  • Paregoric is useful for the treatment of diarrhea.
Usual Adult Dosage
  • 5 to 10 mL (1 to 2 teaspoonfuls) 1 to 4 times a day or as directed by a physician.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Paregoric in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Paregoric in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Usual Pediatric Dosage

0.25 to 0.5 mL/kg of body weight 1 to 4 times a day or as directed by a physician.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Paregoric in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Paregoric in pediatric patients.

Contraindications

  • Condition1

Warnings

Title
See full prescribing information for complete Boxed Warning.
ConditionName:
  • Content
  • Description

Precautions

  • Description

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Paregoric in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Paregoric in the drug label.

Drug Interactions

  • Drug
  • Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Paregoric in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Paregoric during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Paregoric with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Paregoric with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Paregoric with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Paregoric with respect to specific gender populations.

Race

There is no FDA guidance on the use of Paregoric with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Paregoric in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Paregoric in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Paregoric in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Paregoric in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral
  • Intravenous

Monitoring

There is limited information regarding Monitoring of Paregoric in the drug label.

  • Description

IV Compatibility

There is limited information regarding IV Compatibility of Paregoric in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Paregoric in the drug label.

Pharmacology

There is limited information regarding Paregoric Pharmacology in the drug label.

Mechanism of Action

Structure

File:Paregoric01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Paregoric in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Paregoric in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Paregoric in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Paregoric in the drug label.

How Supplied

Storage

There is limited information regarding Paregoric Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Paregoric |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Paregoric |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Paregoric in the drug label.

Precautions with Alcohol

  • Alcohol-Paregoric interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ Empty citation (help)
  2. ↑ "http://www.ismp.org". External link in |title= (help)



{{#subobject: 

 |Label Page=Paregoric
 |Label Name=Paregoric11.png

}}


{{#subobject: 

 |Label Page=Paregoric
 |Label Name=Paregoric11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Paregoric&oldid=1091642"